Prospective Multicenter Phase II Study of Myeloablative Conditioning of Iv Busulfan, Fludarabine +/− Low Dose TBI Intensified by G-CSF-Priming and Cytarabine for Myeloid Malignancies in Older Patients (≥55 Years): Final Analysis of the JSCT FB13 Study
Biology of Blood and Marrow Transplantation - Netherlands
doi 10.1016/j.bbmt.2017.12.421
Full Text
Open PDFAbstract
Available in full text
Date
March 1, 2018
Authors
Publisher
Elsevier BV